28.04.2011 • NewsMerck & Co.Kenneth Frazierportfolio

Merck & Co to Buy Back Up To $5 Billion Of Its Shares

Merck & Co said on Wednesday it plans to buy back up to $5 billion in shares, bringing its total share buyback program to $6.4 billion.
The Whitehouse Station, New Jersey-based drugmaker said the stock purchase has no time limit and will be made on the open market, in block transactions or privately negotiated transactions.

"Merck has a history of leadership in returning cash to shareholders," said Kenneth Frazier, Merck's chief executive officer. "Today's action reflects our confidence in Merck's strategy and demonstrates our commitment to delivering shareholder value."

The company still has $1.4 billion remaining from a share repurchase authorization announced in November 2009.

Company

Logo:

Merck & Co

126 East Lincoln Avenue
07065 Rahway
US

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.